Similarly, within AD, APOE ε4 carriers (n = 41) were assigned higher probability of being classified as AD than the non-carriers (n = 13, Cohen’s d = 0.40, t = 1.37, p = 0.18, Supplementary Fig. S9). This evidence concerns the gene APOE and Alzheimer disease.